𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agentd-19575 (glufosfamide) in patients with solid tumors

✍ Scribed by Toshio Shimizu; Isamu Okamoto; Kenji Tamura; Taroh Satoh; Masaki Miyazaki; Yusaku Akashi; Tomohiro Ozaki; Masahiro Fukuoka; Kazuhiko Nakagawa

Publisher
Springer
Year
2009
Tongue
English
Weight
456 KB
Volume
65
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase I clinical trial and pharmacokinet
Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors
✍ Charles L. Vogel; Elizabeth Gorowski; Enrique Davila; Mario Eisenberger; James K πŸ“‚ Article πŸ“… 1987 πŸ› Springer US 🌐 English βš– 823 KB

ICRF-187 was given to 62 evaluable patients with advanced solid tumors in a Phase I clinical trial. Weekly infusions were given in dosages ranging from 0.85 g/m2 to 7.42 g/m2 for a total of four weeks with a two week rest period between courses. Dose-limiting hematological toxicity was seen in heavi

Phase I and pharmacokinetic study of a s
Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors : The relation between pharmacokinetic property and toxicity
✍ Ruey-Long Hong; Yun-Long Tseng πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 99 KB πŸ‘ 2 views

## BACKGROUND. Compared with free drug, sterically stabilized liposomal drug has prolonged circulation time and, thereby, higher tumor selectivity and antitumor activity. The stability in plasma is an important consideration in the formulation of clinically useful liposomal drug. A Phase I study o